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distal portion of the LAD) in normal coronary arteries on the same
angiogram, in fact, seem to constrict without aneurysm, suggesting
that normal coronary arteries after KD also exhibit impaired
ACh-induced vasodilation in their protocol. In other words, even
the proximal portion of the LAD could constrict due to only the
history of KD, without the effect of aneurysm. The cause of
segmentally heterogeneous ACh responses is immediately un-
known. To demonstrate the association between aneurysm or
history of KD and ACh responses, specific diameter-matched and
corresponding segments should be compared among risk factor–
matched groups (2–5). Although Yamakawa et al. tried to compare
each segment between study groups, they only referred to the
“trend” of the difference, not the statistical difference in each
segment between study groups. In addition, comparable ACh-
induced vascular responses among different types of lesions, as
evaluated in multiple segments of patients in their report, would
not preclude the possibility that some susceptible segments with-
out aneurysms in KD groups exhibit abnormal ACh responses, as
shown in our report (3).
Interpretation of the results. Although Yamakawa et al. showed
impaired ACh-induced vasodilation in regressed aneurysm, it
might not be concluded that “endothelial function” is impaired in
these lesions, unless normal responses to an endothelium-
independent vasodilator are shown (2,3). In addition, the high
concentration of ACh, as used in their protocol, could elicit a
stronger “direct” vasoconstrictor response in the disease state,
which could have been misinterpreted as representing impaired
endothelial function (2). Accordingly, a more accurate conclusion
would be that “ACh-induced vasodilation” is impaired late after
KD.
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REPLY
We appreciate the kind comments of Dr. Mitani regarding our
report and for sharing their experiences with us. We agree with
him that the adequate dosage of acetylcholine (ACh) required to
assess vascular function is uncertain for children. Thus, we pre-
liminarily studied the effects of different doses (5, 15, 30 and
50 mg) in a normal coronary artery and in regressed coronary
aneurysms after Kawasaki disease (KD) in four children. If we used
50 mg of ACh, the normal coronary artery became constricted, and
if 5 mg was used, the normal coronary artery did not dilate. When
we used 15 mg and 30 mg of ACh, significant dilation was observed
in the normal coronary arteries, and vasoconstriction appeared in
the regressed aneurysms. Thus, we chose a lower dose of 15 mg of
ACh in this study. Thus, 15 mg of ACh chloride was diluted in 5
ml of warm 0.9% saline solution (to produce a coronary blood
concentration of ;3.0 3 1026 mol/liter) and was infused into the
left or right coronary artery (LCA or RCA) over 30 s. In addition,
in the other study in question, a similar dose of ACh was used to
assess endothelium-dependent vasomotor function (2).
In our study, we measured normal sites where coronary aneu-
rysms had not developed to the acute stage and also demonstrated
normal findings at follow-up coronary angiography. We chose
these sites to include coronary segments located at least 10 mm
from the site of previous aneurysms to eliminate the effects of
vasoconstriction or vasodilation of other sites, as shown in Figure
3 in our article. The distal portion of the left anterior descending
coronary artery (LAD) seems to constrict from reducing the
proximal coronary flow caused by vasoconstriction of the distal
portion of this artery (Fig. 3). In addition, there was no significant
difference in the ACh responses between the LCA (11.2 6 6.3%)
and RCA (13.1 6 8%) (p 5 NS) in our control subjects.
Mitani et al. (3) have reported that constriction of a normal
region of the coronary artery after KD was constricted with ACh
infusion. However, several differences existed between our study
and their study. The interval between KD onset and the time of
their investigation was shorter than that in our study (3). Patho-
logic studies have demonstrated that infiltration by inflammatory
cells can occur in the coronary artery, even within six months after
the acute phase of KD (4,5). We studied only patients with KD
with an interval .10 years after the onset of KD to eliminate any
direct effects of acute KD vasculitis. In addition, their patients did
not have a complete normal coronary artery at the acute stage;
instead, they had only a normal LAD. In contrast, in our new
study, we investigated the vascular function of the coronary artery
using an intracoronary infusion of ACh chloride and isosorbide
dinitrate (ISDN) in five patients with KD who had a completely
normal first coronary angiogram (6). The patients with a normal
coronary artery after KD were not significantly different, in their
response to either ACh or ISDN infusion, from the control subjects.
These findings suggest that such coronary arteries had normal
function of the endothelium and smooth muscle even over the long
term. On the basis of our studies (1,6,7), we conclude that patients
with long-term persistent coronary aneurysms and regressed coronary
aneurysms after KD have vascular dysfunction. These patients should
be counseled to avoid potential risk factors for atherosclerosis and that
long-term follow-up is needed into adulthood.
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